Efficacy of a Low-Cost, inactivated Whole-Cell oral cholera vaccine: Results from 3 years of Follow-Up of a randomized, controlled trial

Background: Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protection conferred by licensed OCVs beyond two years of follow-up has not been demonstrated in randomized, clinical trials. Methods/Principal Findings: We conducted a cluster-randomized, placebo...

Full description

Bibliographic Details
Main Authors: Sur, D., Kanungo, S., Sah, B., Manna, B., Ali, Mohammed, Paisley, A., Niyogi, S., Park, J., Sarkar, B., Puri, M., Kim, D., Deen, J., Holmgren, J., Carbis, R., Rao, R., van Thu, N., Han, S., Attridge, S., Donner, A., Ganguly, N., Bhattacharya, S., Nair, G., Clemens, J., Lopez, A.
Format: Journal Article
Published: Public Library of Science 2011
Online Access:http://hdl.handle.net/20.500.11937/65448